EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

July 1, 2025

Study Completion Date

December 31, 2025

Conditions
Familial MelanomaFear of Cancer RecurrenceEye Movement Desensitization and ReprocessingPsychological Intervention
Interventions
OTHER

eye movement desensitization and reprocessing (EMDR)

"EMDR is a psychological intervention that has historically been applied to the treatment of Post-Traumatic Stress Disorder (PTSD), but has since then been shown to be effective for a variety of anxiety disorders (e.g. fear of illness and specific phobia) (Logie \& de Jongh, 2014) and somatic complaints such as post-operative pain, medically unexplained symptoms and seizure-related post-traumatic stress (Dautovic, de Roos, van Rood, Dommerholt, \& Rodenburg, 2016; van Rood \& de Roos, 2009; Maroufi, Zamani, Izadikhah, Marofi, \& O'Connor, 2016).~With more than 25 randomized clinical trials, EMDR has been established as an evidence-based intervention for PTSD and PTSD symptomatology including physical symptoms and fear of future catastrophes (Balkom van et al., 2013)."

Trial Locations (2)

2333ZA

RECRUITING

Leiden University Medical Center, Leiden

RECRUITING

Leiden University Medical Centre, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

lead

Leiden University Medical Center

OTHER

NCT06767332 - EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial | Biotech Hunter | Biotech Hunter